Abstract
Bleomycin produced regression of tumours in 10 of 15 cases of human squamous cell carcinoma. Hearing and equilibrium were not affected. No ototoxic effects were found in guinea pigs when Bleomycin was administered subcutaneously and intraperi-toneally. Cochlear damage was seen when the drug was injected into the middle ear.